Assessment of the efficacy of various neoadjuvant anti-HER2 targeted therapies combined with chemotherapy for HER2-positive breast cancer in the real-world setting and development of a predictive model for pathological complete response
{{output}}
Background: The development of a robust and clinically applicable predictive model for pathological complete response (pCR) following neoadjuvant therapy (NAT) in human epidermal growth factor receptor 2 (HER2)-positive breast ca... ...
